DK0970099T3 - Fremgangsmåde til fremstilling af erythromycin A-oxim - Google Patents

Fremgangsmåde til fremstilling af erythromycin A-oxim

Info

Publication number
DK0970099T3
DK0970099T3 DK97907949T DK97907949T DK0970099T3 DK 0970099 T3 DK0970099 T3 DK 0970099T3 DK 97907949 T DK97907949 T DK 97907949T DK 97907949 T DK97907949 T DK 97907949T DK 0970099 T3 DK0970099 T3 DK 0970099T3
Authority
DK
Denmark
Prior art keywords
erythromycin
oxime
preparation
isopropanol
acetic acid
Prior art date
Application number
DK97907949T
Other languages
Danish (da)
English (en)
Inventor
Sou-Jen Chang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24526649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0970099(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0970099T3 publication Critical patent/DK0970099T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97907949T 1996-04-10 1997-02-27 Fremgangsmåde til fremstilling af erythromycin A-oxim DK0970099T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/630,306 US5808017A (en) 1996-04-10 1996-04-10 Process for preparing erythromycin A oxime
PCT/US1997/003177 WO1997038000A1 (en) 1996-04-10 1997-02-27 Process for preparing erythromycin a oxime

Publications (1)

Publication Number Publication Date
DK0970099T3 true DK0970099T3 (da) 2003-05-26

Family

ID=24526649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97907949T DK0970099T3 (da) 1996-04-10 1997-02-27 Fremgangsmåde til fremstilling af erythromycin A-oxim

Country Status (8)

Country Link
US (1) US5808017A (de)
EP (1) EP0970099B1 (de)
JP (1) JP4004068B2 (de)
AT (1) ATE232210T1 (de)
DE (1) DE69718942T2 (de)
DK (1) DK0970099T3 (de)
ES (1) ES2191821T3 (de)
WO (1) WO1997038000A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE269350T1 (de) * 1997-07-08 2004-07-15 Biochemie Sa Solvate von erythromycin a oxim
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
IN190782B (de) * 1998-09-30 2003-08-23 Max India Ltd
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
EP1254146B1 (de) 1999-12-16 2005-08-24 Teva Pharmaceutical Industries Ltd. Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
US6590084B2 (en) 1999-12-20 2003-07-08 Merial Process for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A
FR2802534B1 (fr) * 1999-12-20 2002-02-01 Merial Sas Procede pour preparer et isoler la 9-deoxo-9 (z)- hydroxyiminoerythromycine a
PL356645A1 (en) 2000-01-11 2004-06-28 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
EP1313486A1 (de) * 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung des clarithromycins und eines clarithromycin-zwischenprodukt; clarithromycin wesentlich frei von oxime; und pharmazeutische zusammensetzung die sie enthalten
DE60138876D1 (de) * 2000-03-28 2009-07-16 Sandoz Ag Geschmackmaskierte granulierte teilchen
DE60114028T2 (de) * 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
WO2003040162A1 (de) * 2001-11-07 2003-05-15 Aventis Pharma Deutschland Gmbh Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
EP1648418A4 (de) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1771158A4 (de) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Tablette für pulsierte abgabe
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin
CN101362783B (zh) * 2008-10-06 2011-12-07 浙江国邦药业有限公司 一种红霉素a(e)肟的制备方法
CN102911225A (zh) * 2011-08-04 2013-02-06 山东方明药业集团股份有限公司 红霉素a肟的清洁化合成方法及其特别组合的反应设备
CN103897002A (zh) * 2012-12-31 2014-07-02 菏泽市方明制药有限公司 一种粗品硫氰酸红霉素制备红霉素a9-肟的方法
CN103923142B (zh) * 2014-04-30 2017-01-11 浙江震元制药有限公司 一种罗红霉素中间体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンaオキシム及びその塩の製造方法

Also Published As

Publication number Publication date
US5808017A (en) 1998-09-15
EP0970099A1 (de) 2000-01-12
ES2191821T3 (es) 2003-09-16
DE69718942D1 (de) 2003-03-13
JP4004068B2 (ja) 2007-11-07
WO1997038000A1 (en) 1997-10-16
ATE232210T1 (de) 2003-02-15
DE69718942T2 (de) 2003-12-11
EP0970099B1 (de) 2003-02-05
JP2000508311A (ja) 2000-07-04

Similar Documents

Publication Publication Date Title
DK0970099T3 (da) Fremgangsmåde til fremstilling af erythromycin A-oxim
RU95102329A (ru) Способ и стабилизированная каталитическая система для получения олефинов
BG103673A (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime derivatives of erythromycin a
MX9205462A (es) Proceso y equipo para teñido de cabello
IE44749L (en) Cyclopeptide
BR9809109A (pt) Composição aglutinante de tinta em pó
EA199800811A1 (ru) Способ получения нитробифенилов
DK0749305T3 (da) Fremgangsmåde til fremstilling af avermectin/zein-sammensætninger
DK0935647T3 (da) Koncentrerede enfasede vandige opløsninger af tetrahydroiso-alfa-syrer og fremgangsmåder til fremstilling af samme
CA2204184A1 (en) End sections of connections for mineral wool conduits of the "climaver plus" type
JPS53121710A (en) Preparation of isomerized chlorofluorohydrocarbon containing hydrogne
ID27440A (id) Proses untuk menyiapkan penengah-penengah
JPS529757A (en) Clamping method of bolt and its washer
JPS5242015A (en) Run length code processing method for facsimile signal
EP0669304A4 (de) Verfahren zur herstellung von difluormethan.
ES439296A1 (es) Procedimiento para la preparacion de anhidrido maleico, a partir de acido maleico.
BR9807726A (pt) Processo para a preparação de um composto
JPS5254083A (en) Microbial productio of glicolipids
JPS51120637A (en) Signal transmission system
JPS51122043A (en) Process for preparation of 3-hydroxy-5- cycloxycyclopento-1-ene deriva tives
JPS52116433A (en) Preparation of benzanilide derivatives
JPS52153915A (en) Preparation of alpha-amino-delta-hydroxyvaleric acid
JPS53120216A (en) Fet self-excited mixer circuit
JPS5377098A (en) Preparation of indoloisoquinoline derivative
MX9704608A (es) Acidos fluoroalquilglicosiduronicos y 6(3)-lactonas correspondientes, preparacion y usos.